BUY ITPP ONLINE 

ITPP (myo-inositol trispyrophosphate) has gained attention in the context of veterinary medicine, particularly for its potential applications in horses and camels, primarily due to its ability to enhance oxygen delivery to tissues. Here’s an overview of its relevance to these animals:

Potential Applications in Horses and Camels

1. Performance Enhancement:
   • Horses and camels used in racing or endurance sports require efficient oxygen delivery to sustain high levels of physical activity.
   • ITPP’s ability to reduce hemoglobin’s affinity for oxygen could theoretically improve stamina and recovery during intense exercise by enhancing tissue oxygenation.
2. Treatment of Hypoxic Conditions:
   • Horses and camels can suffer from conditions such as exercise-induced pulmonary hemorrhage (EIPH) or other respiratory and circulatory issues that impair oxygen delivery.
   • ITPP might help alleviate hypoxia-related complications by improving oxygen supply to affected tissues.
3. Recovery Aid:
   • For animals recovering from illness or injury, ITPP could assist in tissue repair and healing by ensuring better oxygenation.

Administration and Dosage

• Routes of Administration:
  • ITPP can be administered intravenously or orally, though the method and frequency depend on the specific condition being addressed.
• Species-Specific Considerations:
  • Dosing regimens for large animals like horses and camels would need to be carefully calibrated based on their size, metabolic rate, and intended use.

Regulatory and Ethical Concerns

1. Doping Concerns:
   • ITPP has raised concerns in competitive sports due to its potential misuse as a performance-enhancing drug.
   • Regulatory bodies like the FEI (Fédération Équestre Internationale) and IFHA (International Federation of Horseracing Authorities) prohibit the use of substances that artificially enhance performance.
   • Testing protocols for detecting ITPP in animals are being developed to ensure fair competition.
2. Safety and Side Effects:
   • Long-term safety studies in horses and camels are limited.
   • Potential side effects, such as metabolic disturbances or impacts on red blood cells, must be thoroughly investigated before widespread use.

Current Research and Status

• Experimental Stage: While promising in theory, the use of ITPP in horses and camels remains largely experimental, with limited clinical trials or peer-reviewed studies specific to these species.
• Ethical Use: Its use is more acceptable for therapeutic purposes (e.g., treating hypoxia) than for performance enhancement, which would violate ethical standards in animal sports.